Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Qinglei Kong
miR-431-5p Alters the Epithelial-To-Mesenchymal Transition Markers by Targeting UROC28 in Hepatoma Cells
OncoTargets and Therapy
Oncology
Pharmacology
Design and Implement of Adaptive Variable Rate Communication System Based on Soc and Rfic
Related publications
miR-190a Inhibits Epithelial-Mesenchymal Transition of Hepatoma Cells via Targeting the Long Non-Coding RNA treRNA
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
miR-125a-5p Inhibits Colorectal Cancer Cell Epithelial–mesenchymal Transition, Invasion and Migration by Targeting TAZ
OncoTargets and Therapy
Oncology
Pharmacology
miR-210-5p Promotes Epithelial–mesenchymal Transition by Inhibiting PIK3R5 Thereby Activating Oncogenic Autophagy in Osteosarcoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
miR-204 Regulates Epithelial-Mesenchymal Transition by Targeting SP1 in the Tubular Epithelial Cells After Acute Kidney Injury Induced by Ischemia-Reperfusion
Oncology Reports
Medicine
Cancer Research
Oncology
miR‑625‑5p Suppresses Inflammatory Responses by Targeting AKT2 in Human Bronchial Epithelial Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
miR-367 Promotes Epithelial-To-Mesenchymal Transition and Invasion of Pancreatic Ductal Adenocarcinoma Cells by Targeting the Smad7-TGF-Β Signalling Pathway
British Journal of Cancer
Cancer Research
Oncology
miR-200C Inhibits Growth of Uterine Carcinosarcoma Cells by Driving a Mesenchymal-To-Epithelial Transition
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Novel Clinical Therapeutics Targeting the Epithelial to Mesenchymal Transition
Clinical and Translational Medicine
Medicine
Molecular Medicine
miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1
Oncology Reports
Medicine
Cancer Research
Oncology